Mixed evidence on the relationship between socioeconomic position and atopic dermatitis: A systematic review - 27/01/22
Abstract |
Background |
Lower socioeconomic position usually portends worse health outcomes, but multiple studies have found that atopic dermatitis is associated with higher socioeconomic position. The nature of this relationship remains unclear.
Objective |
To systematically review the literature on socioeconomic position and atopic dermatitis and determine whether the association varies by patient or study characteristics.
Methods |
A literature search was conducted in the PubMed and Embase databases. Individual-level studies addressing the association between all measures of socioeconomic position and the prevalence or incidence of atopic dermatitis were eligible for inclusion. Two independent reviewers screened all texts and extracted all data for qualitative synthesis.
Results |
Eighty-eight studies met the inclusion criteria. Of the 88 studies, 42% (37) found a positive association between atopic dermatitis and socioeconomic position, 15% (13) found a negative association, and 43% (38) found a null or inconsistent association. Studies conducted in Europe, among children, and based on self-report of eczema were more likely to find a positive association with socioeconomic position.
Limitations |
Studies varied both in terms of the measurement of socioeconomic position and the definition of atopic dermatitis, limiting quantitative synthesis.
Conclusion |
The evidence of a positive association between atopic dermatitis and socioeconomic position is not consistent.
Le texte complet de cet article est disponible en PDF.Key words : atopic, dermatitis, eczema, socioeconomic position, socioeconomic status
Abbreviation used : SEP
Plan
| Funding sources: The authors received no specific funding for this work. Dr Langan is supported by a Wellcome senior research fellowship in clinical science (205039/Z/16/Z). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. Dr Langan is also supported by Health Data Research UK (grant no. LOND1), which is funded by the United Kingdom Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health & Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation, and Wellcome Trust. Dr Abuabara receives funding from National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR073915). The views in this manuscript do not necessarily represent the views of the funders. |
|
| IRB approval status: Not applicable. |
Vol 86 - N° 2
P. 399-405 - février 2022 Retour au numéro
Article précédent
- The completeness and accuracy of DataDerm: The database of the American Academy of Dermatology
- Marta Van Beek, Robert A. Swerlick, Barbara Mathes, Margo J. Reeder, Toni Kaye, Arik Aninos, Matthew E. Fitzgerald, Caryn D. Etkin, Jeffrey P. Jacobs
- Janus kinase inhibitors in dermatology: Part I. A comprehensive review
- Stephanie Chapman, Michael Kwa, Linda Stein Gold, Henry W. Lim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?